N A Ial'chenko, V D Lagutin, N N Levik, O K Nekhaev
{"title":"[用免疫酶法测定肺癌癌胚抗原]。","authors":"N A Ial'chenko, V D Lagutin, N N Levik, O K Nekhaev","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Elevation of the carcinoembryonal antigen concentration in patients with pulmonary carcinoma is directly dependent on the tumor process dissemination. Measurements of mucinous cancer-associated antigen, neurospecific enolase, CA-125 improve the reliability of enzyme immunoassays of tumor markers of lung cancer. Measurements of carcinoembryonic antigen over the course of treatment may become a valuable test permitting an objective assessment of the treatment efficacy.</p>","PeriodicalId":18012,"journal":{"name":"Laboratornoe delo","volume":" 6","pages":"36-8"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay].\",\"authors\":\"N A Ial'chenko, V D Lagutin, N N Levik, O K Nekhaev\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Elevation of the carcinoembryonal antigen concentration in patients with pulmonary carcinoma is directly dependent on the tumor process dissemination. Measurements of mucinous cancer-associated antigen, neurospecific enolase, CA-125 improve the reliability of enzyme immunoassays of tumor markers of lung cancer. Measurements of carcinoembryonic antigen over the course of treatment may become a valuable test permitting an objective assessment of the treatment efficacy.</p>\",\"PeriodicalId\":18012,\"journal\":{\"name\":\"Laboratornoe delo\",\"volume\":\" 6\",\"pages\":\"36-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Laboratornoe delo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratornoe delo","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay].
Elevation of the carcinoembryonal antigen concentration in patients with pulmonary carcinoma is directly dependent on the tumor process dissemination. Measurements of mucinous cancer-associated antigen, neurospecific enolase, CA-125 improve the reliability of enzyme immunoassays of tumor markers of lung cancer. Measurements of carcinoembryonic antigen over the course of treatment may become a valuable test permitting an objective assessment of the treatment efficacy.